Enhancement of nitric oxide synthase induction in alveolar macrophages by in vivo administration of docetaxel

European Journal of Pharmacology

Volumn 580, Issue 3, 2008, Pages 425-430

  Saito, Fumiaki ^a   Matsusaka, Satoshi ^a   Takahashi, Yuji ^a,b   Wakabayashi, Ichiro ^a,b  

^a YAMAGATA UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Docetaxel; Immunity; Lipopolysaccharide; Macrophage; Nitric oxide

Indexed keywords

DOCETAXEL; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INDUCTION; IN VITRO STUDY; IN VIVO STUDY; ISOLATION PROCEDURE; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIMULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CATTLE; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INJECTIONS, INTRAPERITONEAL; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, WISTAR; TAXOIDS;

EID: 38349084113     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.006     Document Type: Article

References (27)

1. Ajizian S.J., English B.K., and Meals E.A. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ. J. Infect. Dis. 179 (1999) 939-944
2. Bissery, M.C., Nohynek, G., Sanderink, G.J., Lavelle, F., 1995. Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: preclinical experience. Anticancer Drugs 6, 339-355, 363-368.
3. Chandler D.B., and Fulmer J.D. Prostaglandin synthesis and release by subpopulations of rat alveolar macrophages. J. Immunol. 139 (1987) 893-898
4. Chandler D.B., Fuller W.C., Jackson R.M., and Fulmer J.D. Fractionation of rat alveolar macrophages by isopycnic centrifugation: morphological, cytochemical, biochemical, and functional properties. J. Leukoc. Biol. 39 (1986) 371-383
5. Chen C.C., and Wang J.K. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol. Pharmacol. 55 (1999) 481-488
6. Choi B.M., Kim Y.M., Jeong Y.R., Pae H.O., Song C.E., Park J.E., Ahn Y.K., and Chung H.T. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 321 (2004) 132-137
7. Cunha F.Q., Moncada S., and Liew F.Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem. Biophys. Res. Commun. 182 (1992) 1155-1159
8. Cvetkovic I., Miljkovic D., Vuckovic O., Harhaji L., Nikolic Z., Trajkovic V., and Mostarica Stojkovic M. Taxol activates inducible nitric oxide synthase in rat astrocytes: the role of MAP kinases and NF-κB. Cell. Mol. Life Sci. 61 (2004) 1167-1175
9. Ding A.H., Porteu F., Sanchez E., and Nathan C.F. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248 4953 (1990) 370-372
10. Eisenhauer E.A., and Vermorken J.B. The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs 55 (1998) 5-30
11. Hibbs Jr. J.B., Taintor R.R., Vavrin Z., and Rachlin E.M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157 (1988) 87-94
12. Hill B.T., Whelan R.D., Shellard S.A., McClean S., and Hosking L.K. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro. Invest New Drugs 12 (1994) 169-182
13. Jun C.D., Choi B.M., Kim H.M., and Chung H.T. Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages. J. Immunol. 154 (1995) 6541-6547
14. Kim Y.M., and Paik S.G. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells. Biochem. Biophys. Res. Commun. 326 (2005) 410-416
15. Lechner M., Lirk P., and Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin. Cancer Biol. 15 (2005) 277-289
16. Lee T.S., and Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8 (2002) 240-246
17. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
18. Manfredi J.J., Parness J., and Horwitz S.B. Taxol binds to cellular microtubules. J. Cell Biol. 94 (1982) 688-696
19. Marczin N., Jilling T., Papapetropoulos A., Go C., and Catravas J.D. Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells. Br. J. Pharmacol. 118 (1996) 1085-1094
20. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
21. Moos P.J., Muskardin D.T., and Fitzpatrick F.A. Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme. J. Immunol. 162 (1999) 467-473
22. Oktem G., Karabulut B., Selvi N., Sezgin C., Sanli U.A., Uslu R., Yurtseven M.E., and Omay S.B. Differential effects of doxorubicin and docetaxel on nitric oxide production and inducible nitric oxide synthase expression in MCF-7 human breast cancer cells. Oncol. Res. 14 (2004) 381-386
23. Rao K.M. MAP kinase activation in macrophages. J. Leukoc. Biol. 69 (2001) 3-10
24. Rowinsky E.K., Donehower R.C., Jones R.J., and Tucker R.W. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 48 (1988) 4093-4100
25. Saito F., Matsusaka S., Kato H., and Wakabayashi I. Inhibitory action of daunorubicin on lipopolysaccharide-stimulated inducible-type nitric oxide synthase induction in alveolar macrophages. J. Pharmacol. Sci. 99 (2005) 364-372
26. Wang M.J., Jeng K.C., and Shih P.C. Differential expression of inducible nitric oxide synthase gene by alveolar and peritoneal macrophages in lipopolysaccharide-hyporesponsive C3H/HeJ mice. Immunology 98 (1999) 497-503
27. Zaks-Zilberman M., Zaks T.Z., and Vogel S.N. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine 15 (2001) 156-165